Middle East & Africa Mammography Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Middle East Mammography Market Analysis

The Middle East & Africa Mammography Market size is estimated at USD 94.32 million in 2025, and is expected to reach USD 136.92 million by 2030, at a CAGR of 7.74% during the forecast period (2025-2030).

The mammography industry in the Middle East and Africa region is experiencing significant transformation driven by technological innovation and healthcare infrastructure development. Advanced medical imaging technologies are revolutionizing breast cancer detection capabilities, with artificial intelligence integration becoming increasingly prevalent in diagnostic procedures. For instance, in November 2023, MICA AI Medical developed the DENISE technology, an artificial intelligence algorithm that has demonstrated a remarkable increase in mammography accuracy to 90% while reducing unnecessary biopsies by 30%. This technological evolution reflects the industry's commitment to improving diagnostic precision while minimizing invasive procedures.

Healthcare accessibility has emerged as a crucial focus area, with mobile mammography units playing a vital role in reaching underserved populations. The Oman Cancer Association's initiative in March 2024 exemplifies this trend, having successfully screened over 25,000 women through mobile mammogram vans in the Sohar and Dhofar regions. This approach has proven particularly effective in addressing the urban-rural healthcare disparity, ensuring that breast cancer screening services reach women in remote areas who might otherwise lack access to these essential diagnostic services.

The industry is witnessing a paradigm shift towards integrated healthcare solutions, combining traditional screening methods with digital mammography innovations. In February 2024, Fujifilm introduced the advanced AMULET SOPHINITY system at the European Congress of Radiology, featuring a Hexagonal Close Pattern structure panel for enhanced image quality and improved patient comfort. This development represents the industry's movement towards patient-centric solutions that balance diagnostic accuracy with patient experience, setting new standards for mammography equipment in the region.

The market landscape is characterized by increasing public-private partnerships and healthcare system modernization efforts. According to data from the Czech National Cancer Control Plan 2030 report, long-term population-based organized screening programs have significantly improved survival rates, with Romania reporting an increase from 32% to 37% in 2022. In August 2023, Saqr Hospital in Ras Al Khaimah, in collaboration with Emirates Health Services, launched the "Initiate Action, Receive Hope" campaign, demonstrating the growing emphasis on coordinated healthcare delivery systems that combine advanced technology with comprehensive patient care protocols.

Middle East Mammography Market Trends

Growing Burden of Breast Cancer

The rising burden of breast cancer cases across the Middle East, Europe, and Africa (MEA) region has become one of the crucial health concerns for healthcare professionals. According to data published by the Global Cancer Observatory (GLOBOCON) in February 2024, the prevalence of breast cancer cases is projected to reach significant levels by 2030, with estimates of 4.86 thousand cases in Saudi Arabia, 12.9 thousand in Romania, and 18.5 thousand in South Africa. The increasing incidence is attributed to various risk factors, including the rising geriatric population and changes in lifestyle patterns, which necessitate early detection through breast cancer screening procedures. Additionally, urban-rural disparities and other socioeconomic factors have contributed to the growing breast cancer burden in the region.

The severity of the breast cancer burden is further highlighted by recent studies and statistics. According to an article published in the Journal of SSM Population Health in March 2024, the incidence rate of breast cancer was 78.3 cases per 100,000 women in Israel in 2022. Furthermore, an article published in the Iraqi National Journal of Medicine in January 2024 revealed that breast cancer remains the most common cancer among women in Iraq, with concerning findings about the lack of early detection and inadequate breast cancer diagnostic facilities contributing to low survival rates. These statistics emphasize the critical need for enhanced diagnostic mammography programs and improved access to diagnostic facilities across the region.

Technological Advancements in the Field of Breast Imaging

The field of breast imaging has witnessed remarkable technological advancements, leading to more accurate and less invasive procedures. In February 2024, Fujifilm introduced an advanced mammography technology, the AMULET SOPHINITY system, at the European Congress of Radiology (ECR) 2024. This system represents a significant advancement with its Hexagonal Close Pattern (HCP) structure panel, providing high-quality images for improved diagnostic accuracy and enhanced patient comfort. Additionally, artificial intelligence integration has revolutionized image interpretation, as evidenced by a study published in the Journal of Applied Sciences in November 2023, which reported that AI algorithms in Saudi Arabian government hospitals demonstrated superior diagnostic performance with 92.8% sensitivity and 91.9% specificity, compared to traditional radiologist interpretation.

The advancement in minimally invasive biopsy techniques and contrast-enhanced mammography has further transformed breast cancer detection capabilities. In January 2023, researchers at New York University Abu Dhabi developed an innovative AI solution for detecting breast cancer in breast ultrasound images, significantly improving the accuracy of lesion detection during breast biopsy procedures. Moreover, the integration of artificial intelligence in mammography systems has shown promising results in reducing false-positive results and enhancing early detection capabilities. These technological innovations have been particularly beneficial in examining denser breast tissues and identifying subtle lesions that might be missed through conventional screening methods, including 3D mammography and breast tomosynthesis.

Investment from Various Organizations in Breast Cancer Screening Campaigns

Organizations across the MEA region have significantly increased their investments in breast cancer screening campaigns, demonstrating a strong commitment to improving awareness and early detection. In October 2023, the Friends of Cancer Patients (FOCP) society launched an extensive "Pink October" campaign, conducting 90 events for free breast cancer screening in the United Arab Emirates. The campaign included comprehensive screening services, with free mammography provided for women aged 40 years and above, along with specialized awareness sessions focusing on breast examination and disease recognition. Similarly, in November 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) expanded its support for breast cancer prevention screening programs in Poland, extending free mammography services to women aged 45-74, significantly broadening the previous age range of 50-69.

Recent initiatives have also focused on innovative approaches to reach wider populations. In October 2023, the Bahrain International Airport introduced a unique community-focused breast cancer awareness campaign, implementing pink passports that provided vital information about breast cancer detection services, including breast ultrasound and mammograms, in collaboration with Bahrain Special Hospital. Additionally, in January 2024, Becton, Dickinson, and Company (BD) established a significant partnership with the Kenyan Government through the National Cancer Institute-Kenya, aimed at improving healthcare diagnostics services in under-developed regions. These investments and partnerships demonstrate a growing commitment to expanding access to mammography services and raising awareness about the importance of regular screening across the region.

Middle East & Africa Mammography Market Geography Segment Analysis

Mammography Market in Middle East and North Africa

The Middle East and North Africa region represents approximately 39% of the total mammography market in 2024, establishing itself as a significant market player in the global landscape. The region's market is primarily driven by the increasing burden of breast cancer and substantial technological advancements in breast diagnostic imaging. Healthcare facilities across the region are increasingly adopting advanced mammography services, particularly in countries like Saudi Arabia and the United Arab Emirates, which have robust healthcare infrastructure. The market is further strengthened by various breast cancer screening campaigns and awareness initiatives launched by government organizations and healthcare institutions. The introduction of contrast-enhanced breast biopsy techniques and advanced diagnostic technologies, particularly in major healthcare centers, has significantly enhanced the region's diagnostic capabilities. Additionally, strategic collaborations between healthcare providers and technology companies have facilitated the implementation of cutting-edge mammography solutions, improving access to advanced breast screening services across the region.

Mammography Market in Central/Eastern Europe

The Central/Eastern European mammography market has demonstrated robust growth, with an impressive growth rate of approximately 7% from 2019 to 2024. The market's expansion is primarily attributed to the region's strong focus on early breast cancer screening and comprehensive screening programs. Countries like Poland, Romania, and Israel have emerged as key markets, driven by their well-established healthcare infrastructure and increasing adoption of advanced mammography technologies. The integration of artificial intelligence in mammography systems has particularly gained traction in this region, with healthcare providers increasingly implementing AI-enabled solutions for improved diagnostic accuracy. The market is characterized by strong public-private partnerships in healthcare delivery, with governments actively supporting breast screening initiatives. Furthermore, the presence of major medical technology companies and their continued investment in research and development has contributed to the market's technological advancement and expansion of mammography services across the region.

Mammography Market in Africa (Excluding North Africa)

The mammography market in Africa (excluding North Africa) is projected to grow at a CAGR of approximately 4% during 2024-2029, indicating steady market development despite infrastructure challenges. The market is predominantly concentrated in South Africa, which serves as the region's primary hub for advanced healthcare services and mammography equipment deployment. The growth is being driven by increasing awareness about breast cancer screening and rising government initiatives to improve healthcare infrastructure. Healthcare providers in the region are gradually adopting modern mammography systems, though the penetration remains concentrated in urban areas. The market is characterized by a growing focus on mobile mammography services to address accessibility challenges in remote areas. International healthcare organizations and equipment manufacturers are increasingly participating in initiatives to improve breast screening accessibility, particularly in countries like Nigeria and Kenya. The region presents significant untapped potential, with opportunities for market expansion through public-private partnerships and healthcare infrastructure development programs.